Genelux (GNLX) Projected to Post Earnings on Friday

Genelux (NASDAQ:GNLX) is expected to release its earnings data before the market opens on Friday, April 4th. Analysts expect Genelux to post earnings of ($0.19) per share for the quarter.

Genelux Stock Down 5.3 %

Shares of NASDAQ GNLX opened at $3.03 on Friday. The stock has a market capitalization of $104.65 million, a P/E ratio of -3.19 and a beta of -1.41. The firm’s 50-day moving average price is $4.05 and its two-hundred day moving average price is $3.09. Genelux has a 52-week low of $1.60 and a 52-week high of $6.50.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Genelux in a research report on Tuesday. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $18.25.

Genelux Company Profile

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer.